MiNK Therapeutics, Inc. (INKT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about MiNK Therapeutics, Inc. (INKT)
Company Performance

Current Price

as of Oct 16, 2024

$0.69

P/E Ratio

N/A

Market Cap

$27.28M

Description

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.

Metrics

Overview

  • HQNew York, NY
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerINKT
  • Price$0.69+3.76%

Trading Information

  • Market Cap$27.28M
  • Float25.33%
  • Average Daily Volume (1m)48,878
  • Average Daily Volume (3m)47,975
  • EPS-$0.49

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$2.70M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$2.86M
  • EV$30.35M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/BN/A
Documents